Form 4 Tracker
Gwen A Melincoff

Director · 1 filing · Latest: Jul 15, 2026

Gain Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
COLL
Melincoff Gwen AJul 2, 2025
Proposed Sale
$30.2947,082$1.4M